Home - Products - Others - Other Targets - Nortrachelogenin-8'-O-beta-glucoside

Nortrachelogenin-8'-O-beta-glucoside

CAS No. 858127-38-5

Nortrachelogenin-8'-O-beta-glucoside( —— )

Catalog No. M29330 CAS No. 858127-38-5

Nortrachelogenin-8'-O-beta-glucoside is a lignan with a diarylhydroxybutyrolactone skeleton which isolated from the leaves and stems of Trachelospermum jasminoides (Lindl.) Lem.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 333 In Stock
5MG 279 In Stock
10MG 423 In Stock
25MG 698 In Stock
50MG 918 In Stock
100MG 1283 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Nortrachelogenin-8'-O-beta-glucoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Nortrachelogenin-8'-O-beta-glucoside is a lignan with a diarylhydroxybutyrolactone skeleton which isolated from the leaves and stems of Trachelospermum jasminoides (Lindl.) Lem.
  • Description
    Nortrachelogenin-8'-O-beta-glucoside is a lignan with a diarylhydroxybutyrolactone skeleton which isolated from the leaves and stems of Trachelospermum jasminoides (Lindl.) Lem.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    858127-38-5
  • Formula Weight
    536.53
  • Molecular Formula
    C26H32O12
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc(cc(C[C@@H](COC1=O)[C@]1(Cc(cc1)cc(OC)c1O)O[C@@H]([C@@H]([C@H]1O)O)O[C@H](CO)[C@H]1O)cc1)c1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • L-allo-Isoleucine

    L-alloisoleucine is a branched chain amino acid and is a stereoisomer of L-isoleucine. It is a common constituent of human plasma (albeit at low levels). L-alloisoleucine is produced as a byproduct of isoleucine transamination. Plasma L-alloisoleucine which is derived from L-isoleucine in vivo can be used for the diagnosis of maple syrup urine disease (MSUD) a genetic disorder.

  • TFIIH Modulator-19

    TFIIH Modulator-19 induces the dimerization of trichothiodystrophy group A protein to modulate TFIIH transcriptional activity.

  • [Pro3]-GIP (Rat)

    High affinity rat GIP receptor partial agonist (Kd = 13 nM). Increases cAMP accumulation in COS-7 cells transfected with rat GIP receptor, while also acting as a competitive antagonist of GIP.